Brain 5-HT1A Receptor PET Binding, Cortisol Responses to Stress, and the Familial Transmission of Suicidal Behavior

Abstract Background The serotonin 1A (5-HT1A) receptor has been implicated in depression and suicidal behavior. Lower resting cortisol levels are associated with higher 5-HT1A receptor binding, and both differentiate suicide attempters with depression. However, it is not clear whether 5-HT1A receptor binding and cortisol responses to stress are related to familial risk and resilience for suicidal behavior. Methods [11C]CUMI-101 positron emission tomography imaging to quantify regional brain 5-HT1A receptor binding was conducted in individuals considered to be at high risk for mood disorder or suicidal behavior on the basis of having a first- or second-degree relative(s) with an early onset mood disorder and history of suicidal behavior. These high-risk individuals were subdivided into the following groups: high risk resilient having no mood disorder or suicidal behavior (n = 29); high risk with mood disorder and no suicidal behavior history (n = 31); and high risk with mood disorder and suicidal behavior (n = 25). Groups were compared with healthy volunteers without a family history of mood disorder or suicidal behavior (n = 34). Participants underwent the Trier Social Stress Task (TSST). All participants were free from psychotropic medications at the time of the TSST and PET scanning. Results We observed no group differences in 5-HT1A receptor binding considering all regions simultaneously, nor did we observe heterogeneity of the effect of group across regions. These results were similar across outcome measures (BPND for all participants and BPp in a subset of the sample) and definitions of regions of interest (ROIs; standard or serotonin system-specific ROIs). We also found no group differences on TSST outcomes. Within the high risk with mood disorder and suicidal behavior group, lower BPp binding (β = −0.084, SE = 0.038, P = .048) and higher cortisol reactivity to stress (β = 9.25, 95% CI [3.27,15.23], P = .004) were associated with higher lethality attempts. There were no significant relationships between 5-HT1A binding and cortisol outcomes. Conclusions 5-HT1A receptor binding in ROIs was not linked to familial risk or resilience protecting against suicidal behavior or mood disorder although it may be related to lethality of suicide attempt. Future studies are needed to better understand the biological mechanisms implicated in familial risk for suicidal behavior and how hypothalamic-pituitary-adrenal axis function influences such risk.

[1]  Stephen C. Strother,et al.  The structure of the serotonin system: A PET imaging study , 2020, NeuroImage.

[2]  B. Birmaher,et al.  Severity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals. , 2019, JAMA psychiatry.

[3]  J. Mann,et al.  Antidepressant medication exposure and 5‐HT1A autoreceptor binding in major depressive disorder , 2019, Synapse.

[4]  Louisa J. Steinberg,et al.  Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding , 2019, The international journal of neuropsychopharmacology.

[5]  W. Drevets,et al.  Quantification of 5-HT1A and 5-HT2A receptor Binding in Depressed Suicide Attempters and Non-Attempters , 2019, Archives of suicide research : official journal of the International Academy for Suicide Research.

[6]  Christine DeLorenzo,et al.  Quantification of Positron Emission Tomography Data Using Simultaneous Estimation of the Input Function: Validation with Venous Blood and Replication of Clinical Studies , 2018, Molecular Imaging and Biology.

[7]  V. Arango,et al.  Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity , 2018, Translational Psychiatry.

[8]  J. Mann,et al.  Higher 5-HT1A autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring – A pilot study , 2018, Psychiatry Research: Neuroimaging.

[9]  Christine DeLorenzo,et al.  Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity? , 2018, Depression and anxiety.

[10]  R. Ogden,et al.  In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder , 2018, Brain Structure and Function.

[11]  M. Laudenslager,et al.  Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters , 2017, Psychoneuroendocrinology.

[12]  Eamonn Ferguson,et al.  Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators , 2017, Psychoneuroendocrinology.

[13]  J. Mann,et al.  Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior. , 2016, JAMA psychiatry.

[14]  P. Xie,et al.  Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies , 2016, BMC Psychiatry.

[15]  J. Mann,et al.  Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior , 2016, Neuropsychopharmacology.

[16]  Claus Svarer,et al.  A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System , 2017, The Journal of Neuroscience.

[17]  R. Parsey,et al.  Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder. , 2015, JAMA psychiatry.

[18]  B. Birmaher,et al.  Familial pathways to early-onset suicide attempt: a 5.6-year prospective study. , 2015, JAMA psychiatry.

[19]  E. Baca-García,et al.  Toward a biosignature for suicide. , 2014, The American journal of psychiatry.

[20]  José N. Nobrega,et al.  Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects , 2014, Neuroscience & Biobehavioral Reviews.

[21]  Adam Ciarleglio,et al.  Higher pretreatment 5‐HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: A naturalistic treatment pilot PET study , 2013, Synapse.

[22]  W. Drevets,et al.  Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression , 2013, Journal of psychopharmacology.

[23]  W. Drevets,et al.  Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression , 2013, European Neuropsychopharmacology.

[24]  R. Parsey,et al.  Reference Region Approaches in PET: a Comparative Study on Multiple Radioligands , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  J. Mann,et al.  The serotonergic system in mood disorders and suicidal behaviour , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[26]  Barbara Stanley,et al.  The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. , 2011, The American journal of psychiatry.

[27]  Christine DeLorenzo,et al.  In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer , 2010, The Journal of Nuclear Medicine.

[28]  R. Parsey,et al.  Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations , 2010, Biological Psychiatry.

[29]  P. Cowen,et al.  5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635. , 2010, Journal of affective disorders.

[30]  Ramin V. Parsey,et al.  Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies. , 2010, Nuclear medicine and biology.

[31]  Ramin V. Parsey,et al.  Positron Emission Tomography Quantification of Serotonin-1A Receptor Binding in Medication-Free Bipolar Depression , 2009, Biological Psychiatry.

[32]  Christine DeLorenzo,et al.  Modeling Considerations for In Vivo Quantification of the Dopamine Transporter using [11C]PE2I and Positron Emission Tomography , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Ramin V. Parsey,et al.  Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality , 2009, Neuropsychopharmacology.

[34]  Arno Klein,et al.  A new method for assessing PET-MRI coregistration , 2009, Medical Imaging.

[35]  R. Todd Ogden,et al.  Simultaneous estimation of input functions: An empirical study , 2008, NeuroImage.

[36]  R Todd Ogden,et al.  Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET , 2008, Journal of Nuclear Medicine.

[37]  G. Fairchild,et al.  Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1 A autoreceptor , 2007, Journal of psychopharmacology.

[38]  Satish Iyengar,et al.  Familial pathways to early-onset suicidal behavior: familial and individual antecedents of suicidal behavior. , 2007, The American journal of psychiatry.

[39]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  J. Mann,et al.  A Review of Prospective Studies of Biologic Predictors of Suicidal Behavior in Mood Disorders , 2007, Archives of suicide research : official journal of the International Academy for Suicide Research.

[41]  B. Leonard HPA and Immune Axes in Stress: Involvement of the Serotonergic System , 2007, Neuroimmunomodulation.

[42]  Ramin V. Parsey,et al.  Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  R Todd Ogden,et al.  Estimation in regression models with externally estimated parameters. , 2005, Biostatistics.

[44]  R Todd Ogden,et al.  Estimation of kinetic parameters in graphical analysis of PET imaging data , 2003, Statistics in medicine.

[45]  C. Kirschbaum,et al.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change , 2003, Psychoneuroendocrinology.

[46]  B. Jacobs,et al.  5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus , 2002, Brain Research.

[47]  Barbara Stanley,et al.  Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. , 2002, Archives of general psychiatry.

[48]  A. Young,et al.  Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice , 2002, Journal of psychopharmacology.

[49]  Frank J. Potter,et al.  A STUDY OF PROCEDURES TO IDENTIFY AND TRIM EXTREME SAMPLING WEIGHTS , 2002 .

[50]  A. Young,et al.  Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice. , 2001, The international journal of neuropsychopharmacology.

[51]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  D J Kupfer,et al.  Serotonin type-1A receptor imaging in depression. , 2000, Nuclear medicine and biology.

[53]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[54]  C Waternaux,et al.  Toward a clinical model of suicidal behavior in psychiatric patients. , 1999, The American journal of psychiatry.

[55]  A. Dale,et al.  High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.

[56]  C. de Montigny,et al.  Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors , 1998, The Journal of Neuroscience.

[57]  J. Mann,et al.  Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients , 1997, Biological Psychiatry.

[58]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[59]  J Foote,et al.  Initial reliability and validity of a new retrospective measure of child abuse and neglect. , 1994, The American journal of psychiatry.

[60]  C. Kirschbaum,et al.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. , 1993, Neuropsychobiology.

[61]  Gerald L. Brown,et al.  Human aggression and suicide. , 1986, Suicide & life-threatening behavior.

[62]  A. Beck,et al.  Classification of suicidal behaviors: I. Quantifying intent and medical lethality. , 1975, The American journal of psychiatry.

[63]  D Lester,et al.  The measurement of pessimism: the hopelessness scale. , 1974, Journal of consulting and clinical psychology.

[64]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[65]  E. Barratt,et al.  Factor Analysis of Some Psychometric Measures of Impulsiveness and Anxiety , 1965, Psychological reports.

[66]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.